{
    "guideline": {
        "id": "PA166104980",
        "name": "Annotation of DPWG Guideline for sertraline and CYP2C19",
        "source": "DPWG",
        "version": 33,
        "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104980",
        "relatedChemicals": [
            {
                "id": "PA451333",
                "name": "sertraline",
                "symbol": null
            }
        ],
        "relatedGenes": [
            {
                "id": "PA124",
                "name": "cytochrome P450 family 2 subfamily C member 19",
                "symbol": "CYP2C19"
            }
        ],
        "recommendation": true
    },
    "recommendations": [
        {
            "id": "PA166299243",
            "name": "Recommendation PA166299243",
            "population": null,
            "classification": {
                "term": "N/A",
                "termId": "guidelineStrength:981501929"
            },
            "relatedChemicals": [
                {
                    "id": "PA451333",
                    "name": "sertraline",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452061606,
                "html": "<p>Do not give doses exceeding 75 mg/day. Guide the dose by response and side effects and/or sertraline plasma concentration.</p>\n"
            },
            "implications": [
                "The risk of side effects is increased. The gene variation leads to increased plasma concentrations of sertraline."
            ],
            "lookupKey": {
                "CYP2C19": "Poor Metabolizer"
            },
            "dosingInformation": true,
            "alternateDrugAvailable": false,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "2"
        },
        {
            "id": "PA166299242",
            "name": "Recommendation PA166299242",
            "population": null,
            "classification": {
                "term": "N/A",
                "termId": "guidelineStrength:981501929"
            },
            "relatedChemicals": [
                {
                    "id": "PA451333",
                    "name": "sertraline",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452061605,
                "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
            },
            "implications": [
                "The gene variation has a minor effect on the sertraline plasma concentration. No effect on side effects was found."
            ],
            "lookupKey": {
                "CYP2C19": "Intermediate Metabolizer"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": false,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "1"
        },
        {
            "id": "PA166299241",
            "name": "Recommendation PA166299241",
            "population": null,
            "classification": {
                "term": "No recommendation",
                "termId": "guidelineStrength:1448526251"
            },
            "relatedChemicals": [
                {
                    "id": "PA451333",
                    "name": "sertraline",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452061604,
                "html": "<p>The guideline does not provide a recommendation for sertraline in normal metabolizers.</p>\n"
            },
            "implications": [
                "The guideline does not provide a description of the impact of a normal metabolizer phenotype on sertraline."
            ],
            "lookupKey": {
                "CYP2C19": "Normal Metabolizer"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": false,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "1"
        },
        {
            "id": "PA166299240",
            "name": "Recommendation PA166299240",
            "population": null,
            "classification": {
                "term": "N/A",
                "termId": "guidelineStrength:981501929"
            },
            "relatedChemicals": [
                {
                    "id": "PA451333",
                    "name": "sertraline",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452061603,
                "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
            },
            "implications": [
                "The gene variation has a negligible effect on the plasma concentration of sertraline. Moreover, no significant effect on response and side effects has been found."
            ],
            "lookupKey": {
                "CYP2C19": "Ultrarapid Metabolizer"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": false,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "1"
        }
    ],
    "citations": [
        {
            "pmid": "34782755",
            "title": "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.",
            "authors": [
                "Brouwer Jurriaan M J L",
                "Nijenhuis Marga",
                "Soree Bianca",
                "Guchelaar Henk-Jan",
                "Swen Jesse J",
                "van Schaik Ron H N",
                "Weide Jan van der",
                "Rongen Gerard A P J M",
                "Buunk Anne-Marie",
                "de Boer-Veger Nienke J",
                "Houwink Elisa J F",
                "van Westrhenen Roos",
                "Wilffert Bob",
                "Deneer Vera H M",
                "Mulder Hans"
            ],
            "journal": "European journal of human genetics : EJHG",
            "year": 2022
        },
        {
            "pmid": "21412232",
            "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
            "authors": [
                "Swen J J",
                "Nijenhuis M",
                "de Boer A",
                "Grandia L",
                "Maitland-van der Zee A H",
                "Mulder H",
                "Rongen G A P J M",
                "van Schaik R H N",
                "Schalekamp T",
                "Touw D J",
                "van der Weide J",
                "Wilffert B",
                "Deneer V H M",
                "Guchelaar H-J"
            ],
            "journal": "Clinical pharmacology and therapeutics",
            "year": 2011
        }
    ],
    "version": "2024-03-25-16-13"
}